Literature DB >> 21473949

Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries.

Agnes Kisser1, Ulrich Heininger, Vasee S Moorthy, Bartholomew D Akanmori, Odile Leroy.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21473949     DOI： 10.1016/j.vaccine.2011.03.008

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  2 in total

Review 1.  Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.

Authors:  Nora Dellepiane; Bartholomew Dicky Akanmori; Sunil Gairola; Suresh S Jadhav; Cathy Parker; Carmen Rodriguez; Swati Srivastava
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

2.  Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda.

Authors:  Jonathan Kitonsa; Abu-Baker Ggayi; Zacchaeus Anywaine; Eva Kisaakye; Laura Nsangi; Vincent Basajja; Mary Nyantaro; Deborah Watson-Jones; Georgi Shukarev; Ine Ilsbroux; Cynthia Robinson; Pontiano Kaleebu
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.